Taiwan FDA registration fd4958c5afba8af7d0cd39569d21cf66
Bott 2nd generation blood glucose testing system
TW: 博特2代血糖測試系統
Taiwan·Risk Class 2·Weiren Technology Co., Ltd.; Ruizhi Biochemical Technology Co., Ltd·Registered Jul 03, 2019 – Jul 03, 2029ActiveRegistration details
- Analysis ID
- fd4958c5afba8af7d0cd39569d21cf66
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- WELLAN TECH CO., LTD.
Product details
- Intended Use
- This product can be quantitatively measured by fresh fingertip whole blood and can be used by diabetics or healthcare professionals.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- QMS/QSD;; 國產;; 委託製造
Dates and status
- Registration Date
- Jul 03, 2019
- Expiry Date
- Jul 03, 2029
About this record
Access comprehensive regulatory information for Bott 2nd generation blood glucose testing system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number fd4958c5afba8af7d0cd39569d21cf66 and manufactured by Weiren Technology Co., Ltd.; Ruizhi Biochemical Technology Co., Ltd. The authorized representative in Taiwan is WELLAN TECH CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices